Newcastle University Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
King’s College London Featured PhD Programmes
Aberdeen University Featured PhD Programmes
Monash University Featured PhD Programmes
10 miles

University of Manchester Biological & Medical Sciences PhD Projects, Programs & Scholarships

We have 254 University of Manchester Biological & Medical Sciences PhD Projects, Programs & Scholarships

  • Biological & Medical Sciences×
  • University of Manchester×
  • clear all
Order by 
Showing 1 to 10 of 254
  EPSRC Centre for Doctoral Training in the Science and Applications of Graphene and Related Nanomaterials (Graphene-NOWNANO)
University of Manchester & Lancaster University, North West Nanoscience Doctoral Training Centre. Graphene NOWNANO is a recently established Centre for Doctoral Training (CDT) at the University of Manchester in partnership with Lancaster University.
  Wellcome Trust 4-year PhD Programme in Quantitative and Biophysical Biology
Have you trained in physics, engineering, mathematics or computer science?. Would you like to use your skills to tackle fascinating and important problems in biology?.
  Very High Energy Electron (VHEE) Radiotherapy: A Potential New Paradigm in Cancer Treatment
  Prof R M. Jones, Dr D Angal-Kalinin, Dr A Subiel
Applications accepted all year round
We seek a candidate to work on dose studies and machine optimisation for VHEE treatment, a potential new paradigm in radiotherapy.
  (A*STAR) Advanced deep-learning approaches for the early diagnosis of Congenital Heart Disease
  Dr D Talavera, Prof B Keavney
Application Deadline: 31 January 2019
Congenital Heart Disease (CHD) is a very common birth defect; it affects around 10 out of 1000 newborns worldwide. Survival into adulthood depends on various aspects.
  (A*STAR) Analysis of the role of microRNAs in the regulation of NF-kappaB dynamics and function
  Prof M White, Dr A P Gilmore
Application Deadline: 31 January 2019
The project will investigate the control of NF-kB. This transcription factor is one of most important cell signalling systems in the body that controls inflammation and cell fate.
  (A*STAR) Can non-coding variants explain missing heritability in familial cancer?
  Prof B Newman, Prof G Evans, Dr M Smith
Application Deadline: 31 January 2019
Heterozygous germline variants in a number of tumour suppressor genes cause a spectrum of familial cancers, including early onset breast-ovarian cancer, and colorectal cancer.
  (A*STAR) Elucidating the role of polyamines in the epidermal skin barrier
  Dr S Cruickshank, Dr K Mace, Dr A Saunders
Application Deadline: 31 January 2019
Delayed wound healing is a major health issue affecting one in 50 people. The process of wound healing is a highly orchestrated process involving many cell types and regulatory networks.
  (A*STAR) Elucidation of molecular footprints of kidney fibrosis through integrative ‘omics’-based analysis
  Prof M Tomaszewski, Dr A Adamson, Prof A Woolf
Application Deadline: 31 January 2019
The fibrosis is a common pathway of structural damage in many kidney diseases. It is usually diagnosed when patients present with an irreversible drop in glomerular filtration rate.
  (A*STAR) Engineering of virus-like particles and novel multimeric assemblies as scaffolds for presentation of viral antigens
  Prof J P Derrick, Dr F Hayes
Application Deadline: 31 January 2019
This project will use structural vaccinology to investigate the potential for de novo engineering of large, synthetic macromolecular assemblies.
  (A*STAR) Investigating the role of Lrg1 in chronic kidney diseases
  Dr S Abraham, Prof M Tomaszewski, Dr N Ashton
Application Deadline: 31 January 2019
Chronic Kidney Disease (CKD) affects 10-20% of adults and is a major and increasing public health burden. CKD has several aetiologies that share a final common pathway characterised by an inadequate angiogenic response to renal hypoxia that could potentially serve to enhance the fibrotic phenotype.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.